Inovio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inovio and other ETFs, options, and stocks.About INO
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP.
CEOJacqueline E. Shea
CEOJacqueline E. Shea
Employees134
Employees134
HeadquartersPlymouth Meeting, Pennsylvania
HeadquartersPlymouth Meeting, Pennsylvania
Founded1983
Founded1983
Employees134
Employees134
INO Key Statistics
Market cap146.34M
Market cap146.34M
Price-Earnings ratio-0.82
Price-Earnings ratio-0.82
Dividend yield—
Dividend yield—
Average volume1.06M
Average volume1.06M
High today$2.10
High today$2.10
Low today$2.10
Low today$2.10
Open price$2.17
Open price$2.17
Volume340.00
Volume340.00
52 Week high$4.08
52 Week high$4.08
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
The current Inovio(INO) stock price is $2.10, with a market capitalization of 146.34M. The stock trades at a price-to-earnings (P/E) ratio of -0.82.
During the trading session on 2025-12-12, Inovio(INO) shares reached a daily high of $2.10 and a low of $2.10. At a current price of $2.10, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for Inovio(INO) stock has reached 340, versus its average volume of 1.06M.
Over the past 52 weeks, Inovio(INO) stock has traded between a high of $4.08 and a low of $1.30.
Over the past 52 weeks, Inovio(INO) stock has traded between a high of $4.08 and a low of $1.30.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own INO. This list is generated using Robinhood data, and it’s not a recommendation.